×
QQQ   283.80 (+0.09%)
AAPL   139.23 (+1.30%)
MSFT   260.26 (+1.47%)
META   163.94 (+2.03%)
GOOGL   2,234.03 (-0.27%)
AMZN   108.92 (+1.42%)
TSLA   685.47 (-1.79%)
NVDA   155.42 (-2.75%)
NIO   21.86 (-2.24%)
BABA   116.03 (-0.63%)
AMD   77.99 (-3.45%)
MU   56.02 (-3.18%)
CGC   3.50 (-3.05%)
T   20.95 (+1.65%)
GE   63.69 (-3.32%)
F   11.52 (-2.46%)
DIS   95.65 (-0.28%)
AMC   13.65 (+2.02%)
PFE   50.94 (+0.55%)
PYPL   71.47 (-0.49%)
NFLX   178.36 (-0.69%)
QQQ   283.80 (+0.09%)
AAPL   139.23 (+1.30%)
MSFT   260.26 (+1.47%)
META   163.94 (+2.03%)
GOOGL   2,234.03 (-0.27%)
AMZN   108.92 (+1.42%)
TSLA   685.47 (-1.79%)
NVDA   155.42 (-2.75%)
NIO   21.86 (-2.24%)
BABA   116.03 (-0.63%)
AMD   77.99 (-3.45%)
MU   56.02 (-3.18%)
CGC   3.50 (-3.05%)
T   20.95 (+1.65%)
GE   63.69 (-3.32%)
F   11.52 (-2.46%)
DIS   95.65 (-0.28%)
AMC   13.65 (+2.02%)
PFE   50.94 (+0.55%)
PYPL   71.47 (-0.49%)
NFLX   178.36 (-0.69%)
QQQ   283.80 (+0.09%)
AAPL   139.23 (+1.30%)
MSFT   260.26 (+1.47%)
META   163.94 (+2.03%)
GOOGL   2,234.03 (-0.27%)
AMZN   108.92 (+1.42%)
TSLA   685.47 (-1.79%)
NVDA   155.42 (-2.75%)
NIO   21.86 (-2.24%)
BABA   116.03 (-0.63%)
AMD   77.99 (-3.45%)
MU   56.02 (-3.18%)
CGC   3.50 (-3.05%)
T   20.95 (+1.65%)
GE   63.69 (-3.32%)
F   11.52 (-2.46%)
DIS   95.65 (-0.28%)
AMC   13.65 (+2.02%)
PFE   50.94 (+0.55%)
PYPL   71.47 (-0.49%)
NFLX   178.36 (-0.69%)
QQQ   283.80 (+0.09%)
AAPL   139.23 (+1.30%)
MSFT   260.26 (+1.47%)
META   163.94 (+2.03%)
GOOGL   2,234.03 (-0.27%)
AMZN   108.92 (+1.42%)
TSLA   685.47 (-1.79%)
NVDA   155.42 (-2.75%)
NIO   21.86 (-2.24%)
BABA   116.03 (-0.63%)
AMD   77.99 (-3.45%)
MU   56.02 (-3.18%)
CGC   3.50 (-3.05%)
T   20.95 (+1.65%)
GE   63.69 (-3.32%)
F   11.52 (-2.46%)
DIS   95.65 (-0.28%)
AMC   13.65 (+2.02%)
PFE   50.94 (+0.55%)
PYPL   71.47 (-0.49%)
NFLX   178.36 (-0.69%)
ETR:CCAP

CORESTATE Capital Stock Forecast, Price & News

€1.40
-0.04 (-2.77%)
(As of 06/28/2022 12:00 AM ET)
Add
Compare
Today's Range
€1.35
€1.45
50-Day Range
€1.35
€8.88
52-Week Range
€1.33
€14.06
Volume
136,390 shs
Average Volume
N/A
Market Capitalization
$47.94 million
P/E Ratio
N/A
Dividend Yield
13.51%
Price Target
€18.50
30 days | 90 days | 365 days | Advanced Chart

Receive CCAP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CORESTATE Capital and its competitors with MarketBeat's FREE daily newsletter.

CCAP Stock Forecast (MarketRank)

Overall MarketRank

2.11 out of 5 stars

Analyst Opinion: 2.0Community Rank: 5.0Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -
CORESTATE Capital logo

About CORESTATE Capital (ETR:CCAP)

CORESTATE Capital Holding S.A. is a real estate investment firm specializing in investments in small to medium sized residential portfolios and commercial real estate markets. The firm seeks to invest in an "anti-cyclical" manner in Europe and expand its club-style deals from purely opportunistic to core-plus and value-add investments. The firm offers investment products in real estate funds, co-investments, and club deals. It prefers to invest in Central Europe, Austria, Switzerland, and Germany. CORESTATE Capital Holding S.A. was founded in 2006 and is based in Luxembourg, Luxembourg with additional offices in Zug, Switzerland; London, United Kingdom; Frankfurt, Germany; and Singapore. CORESTATE Capital Holding S.A. operates as a subsidiary of Flygon Holding LLC.

CCAP Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Real Estate Services
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
741
Year Founded
N/A

Company Calendar

Today
6/29/2022
Next Earnings (Estimated)
8/09/2022

Price Target and Rating

Average Stock Price Forecast
€18.50
High Stock Price Forecast
€27.00
Low Stock Price Forecast
€10.00
Forecasted Upside/Downside
+1,219.5%
Consensus Rating
N/A
Rating Score (0-4)
2.33333333333333
Research Coverage
0 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$217.50 million
Cash Flow
€1.69 per share
Book Value
€17.94 per share

Miscellaneous

Free Float
N/A
Market Cap
$47.94 million
Optionable
Not Optionable
Beta
N/A














CORESTATE Capital Frequently Asked Questions

What is CORESTATE Capital's stock price forecast for 2022?

0 Wall Street analysts have issued 1 year price targets for CORESTATE Capital's shares. Their CCAP stock forecasts range from €10.00 to €27.00. On average, they expect CORESTATE Capital's share price to reach €18.50 in the next twelve months. This suggests a possible upside of 1,219.5% from the stock's current price.
View analysts' price targets for CORESTATE Capital
or view top-rated stocks among Wall Street analysts.

How has CORESTATE Capital's stock performed in 2022?

CORESTATE Capital's stock was trading at €11.28 at the start of the year. Since then, CCAP shares have decreased by 87.6% and is now trading at €1.40.
View the best growth stocks for 2022 here
.

When is CORESTATE Capital's next earnings date?

CORESTATE Capital is scheduled to release its next quarterly earnings announcement on Tuesday, August 9th 2022.
View our earnings forecast for CORESTATE Capital
.

Is CORESTATE Capital a good dividend stock?

CORESTATE Capital(ETR:CCAP) pays an annual dividend of €2.50 per share and currently has a dividend yield of 13.51%. CCAP has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.

Who are CORESTATE Capital's key executives?

CORESTATE Capital's management team includes the following people:
  • Mr. Stavros Efremidis, CEO & Member of Management Board (Age 54)
  • Ms. Silke Hechle, Founder
  • Mr. Christine Winter, Founder
  • Mr. Udo Giegerich, CFO & Member of Management Board (Age 53)
  • Ms. Izabela Danner, COO & Member of the Management Board
  • Mr. Ralf Struckmeyer, Chief Investment Officer & Member of the Management Board (Age 49)
  • Ms. Nadja Hoppe, Head of Corp. Fin. & Sales
  • Dr. Kai Gregor Klinger, Chief Markets Officer
  • Ms. Kathrin Aigner, Chief Compliance Officer
  • Dr. Katharina Kneisel, Group Gen. Counsel

What other stocks do shareholders of CORESTATE Capital own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CORESTATE Capital investors own include Lakeland Industries (LAKE), AbbVie (ABBV), Ovintiv (OVV), SIG (SHI), American Airlines Group (AAL), Apollo Investment (AINV), Aravive (ARAV), Apollo Commercial Real Estate Finance (ARI), Berry (BRY) and 41578029 (BT.L) (BT).

What is CORESTATE Capital's stock symbol?

CORESTATE Capital trades on the ETR under the ticker symbol "CCAP."

What is CORESTATE Capital's stock price today?

One share of CCAP stock can currently be purchased for approximately €1.40.

How much money does CORESTATE Capital make?

CORESTATE Capital (ETR:CCAP) has a market capitalization of $47.94 million and generates $217.50 million in revenue each year.

How many employees does CORESTATE Capital have?

CORESTATE Capital employs 741 workers across the globe.

How can I contact CORESTATE Capital?

CORESTATE Capital's mailing address is 11100 Santa Monica Blvd Ste 2000, Los Angeles, California 90025-3335. The official website for CORESTATE Capital is www.corestate-capital.ch. The company can be reached via phone at 352 26 6372 20.

This page (ETR:CCAP) was last updated on 6/29/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.